FAQ 1

What is the Prostate Cancer Risk Management Programme?

One of the main aims of the programme is to ensure that men who are concerned about prostate cancer and considering a PSA test are given clear and balanced information about the benefits, limitations and risks associated with the test. Evidence based materials have therefore been produced by the NHS Cancer Screening Programmes and Cancer Research UK to help GPs provide patients with an informed choice about whether or not to have the test.

The PCRMP was initially announced by the Secretary of State for Health as part of the NHS Prostate Cancer Programme in September 2000 and a primary care information pack was published in 2002. This information pack has now been reviewed and updated to include the latest evidence and information.

Back to frequently asked questions.